Behavioural despair in rats: A new model sensitive to antidepressant treatments

https://doi.org/10.1016/0014-2999(78)90118-8Get rights and content

Abstract

Rats when forced to swim in a cylinder from which they cannot escape will, after an initial period of vigorous activity, adopt a characteristic immobile posture which can be readily identified. Immobility was reduced by various clinically effective antidepressant drugs at doses which otherwise decreased spontaneous motor activity in an open field. Antidepressants could thus be distinguished from psychostimulants which decreased immobility at doses which increased general activity. Anxiolytic compounds did not affect immobility whereas major tranquilisers enhanced it. Immobility was also reduced by electroconvulsive shock, REM sleep deprivation and “enrichment” of the environment. It was concluded that immobility reflects a state of lowered mood in the rat which is selectively sensitive to antidepressant treatments. Positive findings with atypical antidepressant drugs such as iprindole and mianserin suggest that the method may be capable of discovering new antidepressants hitherto undetectable with classical pharmacological tests.

References (63)

  • A. Coston et al.

    Etude neuroélectrophysiologique chez le chat d'un nouveau psychotrope: latoloxatone

    Thérapie

    (1975)
  • R. De Alarcon et al.

    Severe depressive mood changes following slow-release intramuscular fluphenazine injection

    Brit. Med. J.

    (1969)
  • W.E. Fann et al.

    Effect of iprindole on amine uptake in man

    Arch. Gen. Psychiat.

    (1972)
  • L. Floru et al.

    Doppelblind-studie mit dem neuen Antidepressivum Viloxazin im Vergleich zu Imipramin bei 50 stationären Patientinnen

    Arzneim. Forsch.

    (1976)
  • M.I. Fluckman et al.

    The pharmacology of iprindole, a new antidepressant

    Psychopharmacologia

    (1969)
  • C. Gouret et al.

    Intéraction de divers psychotropes avec cinq effects de la réserpine chez la souris et le chat: ptose palpébrale, hypothermie, hypomotilité, catalepsie et pointes pontogéniculo-occipitales: intérêt des tests en psychopharmacologie

    J. Pharmacol. (Paris)

    (1977)
  • C. Gouret et al.

    Activité de la toloxatone, d'antidépresseurs et de divers autres antagonistes de la réserpine sur trois épreuves de comportement chez la souris traitée par la nialamide

    Thérapie

    (1975)
  • C. Gouret et al.

    Profil psychopharmacologique d'un antidépresseur potential appartenant à la série de l'hydroxymethyl-5-oxazolidinone-2

    Thérapie

    (1973)
  • D.T. Greenwood

    Animal pharmacology of viloxazine (Vivalan)

    J. Intern. Med. Res.

    (1975)
  • H. Helmchen et al.

    Depressive Syndrome im Verlauf neuroleptischer Therapie

    Nervenarzt

    (1967)
  • P. Hunt et al.

    Nomifensine: a new potent inhibitor of dopamine uptake into synaptosomes from rat brain corpus striatum

    J. Pharm. Pharmacol.

    (1974)
  • I. Hoffmann

    8-Amino-4-methyl-1-4-phenyl-1,2,3,4-tetrahydroisoquinoline, a new antidepressant

    Arzneim. Forsch.

    (1973)
  • R. Ilaria et al.

    Convulsive therapy and other biological treatments

  • T.M. Itil et al.

    Clinical and EEG effects of GB 94, a ‘tetracyclic’ antidepressant (EEG model: discovery of a new psychotropic drug)

    Curr. Therap. Res. Exp.

    (1972)
  • M. Jalfre et al.

    Effects of some centrally acting agents in rats after intraventricular injections of 6-hydroxydopamine

  • M. Jalfre et al.

    Methods for assessing the interaction of agents with 5-hydroxytryptamine neurons and receptors in the brain

    Advan. Biochem. Psychopharmacol.

    (1974)
  • M.O. Jaskari et al.

    Three double blind comparative trials of mianserine (ORG GB 94) and amitryptyline in the treatment of depressive illness

    Pharmakopsychiat. Neuropsychopharmakol.

    (1977)
  • W.F. Kafoe et al.

    The effect of a new tetracyclic antidepressant compound, ORG GB 94, on the turnover of dopamine, noradrenaline and serotonin in the rat brain

    Arch. Intern. Pharmacodyn. Therap.

    (1973)
  • J.P. Kan et al.

    Study of a new oxazolidinone with original MAO inhibiting properties

  • B.K. Koe

    Molecular geometry of inhibitors of the uptake of catecholamines amd serotonin in synaptosomal preparations of rat brain

    J. Pharmacol. Exptl. Therap.

    (1976)
  • J.C. LeDouarec et al.

    Pharmacology and biochemistry of fenfluramine

  • Cited by (0)

    View full text